André Duvinage

1.8k total citations · 1 hit paper
24 papers, 1.1k citations indexed

About

André Duvinage is a scholar working on Cardiology and Cardiovascular Medicine, Complementary and alternative medicine and Epidemiology. According to data from OpenAlex, André Duvinage has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cardiology and Cardiovascular Medicine, 12 papers in Complementary and alternative medicine and 2 papers in Epidemiology. Recurrent topics in André Duvinage's work include Cardiovascular Function and Risk Factors (16 papers), Heart Failure Treatment and Management (12 papers) and Cardiovascular and exercise physiology (12 papers). André Duvinage is often cited by papers focused on Cardiovascular Function and Risk Factors (16 papers), Heart Failure Treatment and Management (12 papers) and Cardiovascular and exercise physiology (12 papers). André Duvinage collaborates with scholars based in Germany, Austria and Netherlands. André Duvinage's co-authors include Frank Edelmann, Rolf Wachter, Burkert Pieske, Martin Halle, Götz Gelbrich, Christoph Herrmann‐Lingen, Gerd Hasenfuß, Hans‐Dirk Düngen, Albrecht Schmidt and Carsten Tschöpe and has published in prestigious journals such as JAMA, PLoS ONE and American Heart Journal.

In The Last Decade

André Duvinage

23 papers receiving 1.0k citations

Hit Papers

Effect of Spironolactone on Diastolic Function and Exerci... 2013 2026 2017 2021 2013 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
André Duvinage Germany 14 867 199 182 94 92 24 1.1k
Raghava S. Velagaleti United States 12 835 1.0× 101 0.5× 143 0.8× 65 0.7× 237 2.6× 21 1.1k
Monika Przewłocka‐Kosmala Poland 20 1.1k 1.2× 81 0.4× 201 1.1× 115 1.2× 190 2.1× 51 1.3k
Rachel Bijou United States 8 739 0.9× 279 1.4× 60 0.3× 64 0.7× 87 0.9× 17 880
Hannes Gaenzer Austria 11 357 0.4× 121 0.6× 60 0.3× 66 0.7× 73 0.8× 13 693
Gemma Salerno Italy 23 1.4k 1.6× 132 0.7× 117 0.6× 209 2.2× 185 2.0× 45 1.6k
Frank P. Brouwers Netherlands 13 622 0.7× 27 0.1× 104 0.6× 67 0.7× 80 0.9× 20 866
Debra Kinan United States 10 939 1.1× 69 0.3× 95 0.5× 93 1.0× 239 2.6× 10 1.0k
G Roul France 15 778 0.9× 183 0.9× 41 0.2× 247 2.6× 220 2.4× 46 1.0k
S.A. Ahn Belgium 10 755 0.9× 32 0.2× 100 0.5× 70 0.7× 246 2.7× 15 905

Countries citing papers authored by André Duvinage

Since Specialization
Citations

This map shows the geographic impact of André Duvinage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Duvinage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Duvinage more than expected).

Fields of papers citing papers by André Duvinage

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Duvinage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Duvinage. The network helps show where André Duvinage may publish in the future.

Co-authorship network of co-authors of André Duvinage

This figure shows the co-authorship network connecting the top 25 collaborators of André Duvinage. A scholar is included among the top collaborators of André Duvinage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Duvinage. André Duvinage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schacky, Clemens von, Johannes Scherr, E Lorenz, et al.. (2023). De Novo Lipogenesis-Related Monounsaturated Fatty Acids in the Blood Are Associated with Cardiovascular Risk Factors in HFpEF Patients. Journal of Clinical Medicine. 12(15). 4938–4938. 2 indexed citations
2.
Gevaert, Andreas B., Birgit Böhm, Inge Goovaerts, et al.. (2023). Effect of Training on Vascular Function and Repair in Heart Failure With Preserved Ejection Fraction. JACC Heart Failure. 11(4). 454–464. 7 indexed citations
3.
Lechner, Katharina, Clemens von Schacky, Johannes Scherr, et al.. (2023). Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial. Clinical Research in Cardiology. 112(11). 1541–1554. 4 indexed citations
4.
Lechner, Katharina, Clemens von Schacky, Johannes Scherr, et al.. (2022). Saturated Fatty Acid Blood Levels and Cardiometabolic Phenotype in Patients with HFpEF: A Secondary Analysis of the Aldo-DHF Trial. Biomedicines. 10(9). 2296–2296. 6 indexed citations
5.
Gevaert, Andreas B., Stephan Mueller, Ephraim B. Winzer, et al.. (2022). Iron Deficiency Impacts Diastolic Function, Aerobic Exercise Capacity, and Patient Phenotyping in Heart Failure With Preserved Ejection Fraction: A Subanalysis of the OptimEx-Clin Study. Frontiers in Physiology. 12. 11 indexed citations
6.
Gevaert, Andreas B., Amaryllis H. Van Craenenbroeck, Steven Van Laere, et al.. (2021). miR-181c level predicts response to exercise training in patients with heart failure and preserved ejection fraction: an analysis of the OptimEx-Clin trial. European Journal of Preventive Cardiology. 28(15). 1722–1733. 18 indexed citations
7.
Lechner, Katharina, Johannes Scherr, E Lorenz, et al.. (2021). Omega-3 fatty acid blood levels are inversely associated with cardiometabolic risk factors in HFpEF patients: the Aldo-DHF randomized controlled trial. Clinical Research in Cardiology. 111(3). 308–321. 16 indexed citations
8.
Korn, Pia von, Stefan Neubauer, André Duvinage, et al.. (2021). Lifestyle Intervention in Chronic Ischaemic Heart Disease and Type 2 Diabetes (the LeIKD study): study protocol of a prospective, multicentre, randomised, controlled trial. BMJ Open. 11(2). e042818–e042818. 4 indexed citations
9.
Korn, Pia von, Shelley E. Keating, Stephan Mueller, et al.. (2020). The Effect of Exercise Intensity and Volume on Metabolic Phenotype in Patients with Metabolic Syndrome: A Randomized Controlled Trial. Metabolic Syndrome and Related Disorders. 19(2). 107–114. 12 indexed citations
10.
Bobenko, Anna, André Duvinage, Meinhard Mende, et al.. (2020). Outcome assessment using estimation of left ventricular filling pressure in asymptomatic patients at risk for heart failure with preserved ejection fraction. IJC Heart & Vasculature. 28. 100525–100525. 3 indexed citations
11.
Bobenko, Anna, Felix Schoenrath, Jan Knierim, et al.. (2019). Exercise Training in Patients with a Left Ventricular Assist Device (Ex-VAD): Rationale and Design of a Multicentre, Prospective, Assessor-Blinded, Randomized, Controlled Trial. European Journal of Heart Failure. 21(9). 1152–1159. 15 indexed citations
12.
Schwedhelm, Edzard, Dorothee Atzler, Rainer H. Böger, et al.. (2018). Relationship between exercise intervention and NO pathway in patients with heart failure with preserved ejection fraction. Biomarkers. 23(6). 540–550. 14 indexed citations
13.
Edelmann, Frank, Anna Bobenko, Götz Gelbrich, et al.. (2017). Exercise Training in Diastolic Heart Failure (Ex-DHF): Rationale and Design of a Multicentre, Prospective, Randomized, Controlled, Parallel Group Trial. European Journal of Heart Failure. 19(8). 1067–1074. 35 indexed citations
14.
Callizo, Josep, Nicolas Feltgen, Thomas Bertelmann, et al.. (2017). Atrial fibrillation in retinal vascular occlusion disease and non-arteritic anterior ischemic optic neuropathy. PLoS ONE. 12(8). e0181766–e0181766. 32 indexed citations
15.
Trippel, Tobias Daniel, Volker Holzendorf, Martin Halle, et al.. (2016). Ghrelin and Hormonal Markers Under Exercise Training in Patients with Heart Failure with Preserved Ejection Fraction: Results from the Ex-DHF Pilot Study. ESC Heart Failure. 4(1). 56–65. 23 indexed citations
16.
Stahrenberg, Raoul, André Duvinage, Meinhard Mende, et al.. (2015). Determinants of Submaximal Exercise Capacity in Patients at Risk for Heart Failure with Preserved Ejection Fraction—results from the DIAST-CHF Study. ESC Heart Failure. 2(2). 76–84. 7 indexed citations
17.
Pilz, Stefan, Frank Edelmann, Andreas Meinitzer, et al.. (2014). Associations of Methylarginines and Homoarginine With Diastolic Dysfunction and Cardiovascular Risk Factors in Patients With Preserved Left Ventricular Ejection Fraction. Journal of Cardiac Failure. 20(12). 923–930. 36 indexed citations
18.
Edelmann, Frank, Volker Holzendorf, Rolf Wachter, et al.. (2014). Galectin-3 in Patients with Heart Failure with Preserved Ejection Fraction: Results from the Aldo-DHF Trial. European Journal of Heart Failure. 17(2). 214–223. 141 indexed citations
19.
Edelmann, Frank, André Duvinage, Silja Schwarz, Raoul Stahrenberg, & Rolf Wachter. (2011). Neurohumorale Aktivierung und maximale Leistungsfähigkeit bei diastolischer Dysfunktion und diastolischer Herzinsuffizienz. DMW - Deutsche Medizinische Wochenschrift. 136(16). 810–815.
20.
Edelmann, Frank, Raoul Stahrenberg, Hans‐Dirk Düngen, et al.. (2011). Impaired physical quality of life in patients with diastolic dysfunction associates more strongly with neurohumoral activation than with echocardiographic parameters. American Heart Journal. 161(4). 797–804. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026